Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
 

The Official Journal Of The International Society For Pharmacoeconomics And Outcomes Research
 INDEXED IN MEDLINE!

Co-Editors-in-Chief

Michael Drummond, MCom, DPhil
(June 2014-June 2018)
University of York
Heslington, York, UK
E-mail: mike.drummond@york.ac.uk
C. Daniel Mullins, PhD
(June 2014-June 2018)
University of Maryland
Baltimore, MD, USA
E-Mail: dmullins@rx.umaryland.edu

Michael Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York.  His particular field of interest is in the economic evaluation of health care treatments and programmes.  He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programmes, services for people with AIDS, eye health care and pharmaceuticals.  He is the author of two major textbooks and more than 550 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader for the European Union Project on the Methodology of Economic Appraisal of Health Technology.  He has been President of the International Society of Technology Assessment in Health Care, and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).  He is currently a member of the Guidelines Review Panels of the National Institute for Health and Clinical Excellence (NICE) in the UK, and is a Principal Consultant for i3Innovus.  In 2008, he received an Honorary Doctor of Science from City University, London.

Value in Health Vision Statement
Value in Health should duplicate ISPOR’s objectives to have the journal reflect the highest scientific quality as possible in the areas of methodological research and health care sciences, services, and policy, whilst maintaining the already broad appeal to the journal it has already attained, and continuing contributions from many world leaders associated with NICE, CMS, and major private health insurers around the globe.

C. Daniel Mullins, PhD is a Professor within the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy.  He received his BS in Economics from M.I.T. and his MA and PhD in Economics from Duke University.  His research and teaching focus on pharmacoeconomics, comparative effectiveness research, and health disparities research.  He is the Principal Investigator of an NIH/NIA sponsored grant on “Response to Medicare Reimbursement Policy Change by Minority and All ESRD Patients” and the lead economist on an NIH/NHLBI grant with Elijah T. Saunders, MD.  He was the Shared Resources Core Director for the NIH-sponsored University of Maryland Center for Health Disparities Research, Training, and Outreach and has served as a co-Investigator on other grants funded by AHRQ, HRSA and the NIH.  He was a member of the Health Systems Research (HSR) study section of the Agency for Healthcare Research and Quality (AHRQ) from 2004 to 2006 and currently is an ad hoc Study Section member for the National Cancer Institute (NCI).

In addition to his work on federal grants, Professor Mullins has designed many cost-effectiveness analyses and budget impact models for both the pharmaceutical and insurance industries.  He is co-Editor-in-Chief for Value in Health and is author/co-author of nearly 150 peer-reviewed articles and book chapters on pharmacoeconomics, outcomes research, and pharmaceutical policy and health disparities research in journals such as The American Journal of Managed Care, The American Journal of Public Health, Cancer, Chest, The Journal of Trauma, Health Services Research, Pharmacoeconomics, Social Science & Medicine, and Transplantation.  Dr. Mullins was a member of the Maryland Health Care Commission Hospital and Ambulatory Surgical Facility Report Card Steering Committee.  Prior to his graduate studies, he was an Actuary and Market Researcher for the John Hancock Insurance Company.  In 2002, he was the recipient of an Outstanding Service Award from the Drug Information Association (DIA) and in 2006 and 2008 he received an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Service Award.  In 2007, he received the Dr. Patricia Sokolove Outstanding Mentor Award from the University of Maryland, Baltimore campus-wide Graduate Student Association.

Value in Health Vision Statement
As the journal of ISPOR, Value in Health should be viewed as interdependent of the Society and mirror its aim to enhance the methods and applications within the fields of pharmacoeconomics and outcomes research, with its content reflecting research that is read and used for medical decision making and reflect empirical applications of readable, reliable, and advanced methodologies with actionable results and conclusions.


Return to Value in Health Main Page

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.